BlackRock’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36M Buy
4,341,462
+87,065
+2% +$902K ﹤0.01% 2726
2025
Q4
$52.6M Sell
4,254,397
-8,726
-0.2% -$93.5K ﹤0.01% 2484
2025
Q3
$37.6M Sell
4,263,123
-97,752
-2% -$760K ﹤0.01% 2687
2025
Q2
$27.8M Buy
4,360,875
+2,525,313
+138% +$14.5M ﹤0.01% 2819
2025
Q1
$8.92M Sell
1,835,562
-87,274
-5% -$722K ﹤0.01% 3371
2024
Q4
$18.4M Sell
1,922,836
-70,844
-4% -$650K ﹤0.01% 3101
2024
Q3
$16.6M Sell
1,993,680
-1,845,695
-48% -$16.8M ﹤0.01% 3153
2024
Q2
$26.2M Sell
3,839,375
-3,220,833
-46% -$13.9M ﹤0.01% 2816
2024
Q1
$17.9M Sell
7,060,208
-2,338,989
-25% -$5.27M ﹤0.01% 3054
2023
Q4
$22.6M Buy
9,399,197
+963,517
+11% +$2.26M ﹤0.01% 2945
2023
Q3
$28.7M Sell
8,435,680
-796,048
-9% -$4.41M ﹤0.01% 2731
2023
Q2
$67.9M Sell
9,231,728
-26,655
-0.3% -$247K ﹤0.01% 2297
2023
Q1
$95.9M Buy
9,258,383
+303,165
+3% +$3.66M ﹤0.01% 2046
2022
Q4
$106M Buy
8,955,218
+561,216
+7% +$8.68M ﹤0.01% 1953
2022
Q3
$176M Sell
8,394,002
-138,835
-2% -$3.86M 0.01% 1568
2022
Q2
$265M Sell
8,532,837
-199,067
-2% -$6.8M 0.01% 1319
2022
Q1
$359M Buy
8,731,904
+655,003
+8% +$28.9M 0.01% 1225
2021
Q4
$351M Buy
8,076,901
+2,249,296
+39% +$102M 0.01% 1297
2021
Q3
$292M Sell
5,827,605
-11,185
-0.2% -$677K 0.01% 1434
2021
Q2
$368M Buy
5,838,790
+230,314
+4% +$14.8M 0.01% 1294
2021
Q1
$521M Buy
5,608,476
+331,528
+6% +$34M 0.02% 963
2020
Q4
$473M Buy
5,276,948
+168,549
+3% +$15.5M 0.02% 937
2020
Q3
$528M Sell
5,108,399
-1,758,241
-26% -$190M 0.02% 720
2020
Q2
$543M Buy
6,866,640
+218,563
+3% +$16.3M 0.02% 666
2020
Q1
$385M Sell
6,648,077
-172,191
-3% -$9.92M 0.02% 755
2019
Q4
$368M Buy
6,820,268
+123,746
+2% +$6.71M 0.01% 1039
2019
Q3
$350M Sell
6,696,522
-195,109
-3% -$9.09M 0.01% 1009
2019
Q2
$333M Buy
6,891,631
+155,055
+2% +$7.43M 0.01% 1052
2019
Q1
$340M Buy
6,736,576
+176,339
+3% +$10.4M 0.02% 1020
2018
Q4
$389M Buy
6,560,237
+209,332
+3% +$13.5M 0.02% 798
2018
Q3
$418M Buy
6,350,905
+978,194
+18% +$57.1M 0.02% 879
2018
Q2
$271M Buy
5,372,711
+901,882
+20% +$47M 0.01% 1215
2018
Q1
$235M Sell
4,470,829
-47,069
-1% -$2.35M 0.01% 1233
2017
Q4
$210M Buy
4,517,898
+93,349
+2% +$3.93M 0.01% 1328
2017
Q3
$179M Buy
4,424,549
+72,562
+2% +$2.63M 0.01% 1446
2017
Q2
$148M Buy
4,351,987
+150,736
+4% +$4.65M 0.01% 1527
2017
Q1
$122M Buy
4,201,251
+4,198,203
+137,736% +$128M 0.01% 1638
2016
Q4
$100K Buy
3,048
+77
+3% +$2.31K ﹤0.01% 2545
2016
Q3
$93K Sell
2,971
-6,026
-67% -$175K ﹤0.01% 2633
2016
Q2
$253K Buy
8,997
+6,352
+240% +$249K ﹤0.01% 1974
2016
Q1
$96K Buy
2,645
+1,151
+77% +$40.7K ﹤0.01% 2013
2015
Q4
$60K Buy
1,494
+718
+93% +$25K ﹤0.01% 1958
2015
Q3
$22K Hold
776
﹤0.01% 2329
2015
Q2
$26K Sell
776
-50
-6% -$1.55K ﹤0.01% 2272
2015
Q1
$24K Hold
826
﹤0.01% 2270
2014
Q4
$22K Hold
826
﹤0.01% 2321
2014
Q3
$17K Hold
826
﹤0.01% 2423
2014
Q2
$18K Sell
826
-57
-6% -$1.33K ﹤0.01% 2434
2014
Q1
$22K Hold
883
﹤0.01% 2311
2013
Q4
$21K Hold
883
﹤0.01% 2338
2013
Q3
$17K Hold
883
﹤0.01% 2349
2013
Q2
$13K Buy
+883
New +$12.8K ﹤0.01% 2495

Other funds holding EBS